Sigma Healthcare Ltd ( (AU:SIG) ) has shared an announcement.
Sigma Healthcare Limited announced its financial results for the year ending January 31, 2025, marking its last as a standalone entity before merging with Chemist Warehouse Group. The company reported a significant increase in normalised revenue and EBIT, attributed to strategic operational execution and the successful onboarding of a new supply contract. The merger is expected to enhance Sigma’s market position, creating a leading wholesaler and retail franchisor with strong growth potential both in Australia and internationally.
More about Sigma Healthcare Ltd
Sigma Healthcare Limited operates in the healthcare industry, focusing on pharmaceutical distribution and retail franchising. The company is known for its Amcal and Discount Drug Stores brands and has a market focus on the distribution of medicines throughout Australia.
YTD Price Performance: 7.01%
Average Trading Volume: 8,058
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €19.7B
Learn more about SIG stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com